Pakko-oireinen häiriö (OCD), näytönastekatsausten kirjallisuusviitteet
Lisätietoa aiheesta
Käypä hoito -toimitus
24.1.2023
Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Pakko-oireinen
häiriö (OCD) «Pakko-oireinen häiriö (OCD)»1 näytönastekatsauksissa arvioitu kirjallisuus.
Kirjallisuutta
- Acevedo N, Bosanac P, Pikoos T ym. Therapeutic Neurostimulation in Obsessive-Compulsive
and Related Disorders: A Systematic Review. Brain Sci 2021;11: «PMID: 34356182»PubMed
- Afshar H, Akuchekian S, Mahaky B ym. Topiramate augmentation in refractory obsessive-compulsive
disorder: A randomized, double-blind, placebo-controlled trial. J Res Med Sci 2014;19:976-81
«PMID: 25538783»PubMed
- Andrade C. Augmentation With Memantine in Obsessive-Compulsive Disorder. J Clin Psychiatry
2019;80: «PMID: 31846244»PubMed
- Askari S, Mokhtari S, Shariat SV ym. Memantine augmentation of sertraline in the treatment
of symptoms and executive function among patients with obsessive-compulsive disorder:
A double-blind placebo-controlled, randomized clinical trial. BMC Psychiatry 2022;22:34
«PMID: 35022014»PubMed
- Bation R, Mondino M, Le Camus F ym. Transcranial direct current stimulation in patients
with obsessive compulsive disorder: A randomized controlled trial. Eur Psychiatry
2019;62:38-44 «PMID: 31525581»PubMed
- Berlin HA, Koran LM, Jenike MA ym. Double-blind, placebo-controlled trial of topiramate
augmentation in treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry
2011;72:716-21 «PMID: 20816027»PubMed
- Bloch MH, McGuire J, Landeros-Weisenberger A ym. Meta-analysis of the dose-response
relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry 2010;15:850-5
«PMID: 19468281»PubMed
- Bloch MH, Wasylink S, Landeros-Weisenberger A ym. Effects of ketamine in treatment-refractory
obsessive-compulsive disorder. Biol Psychiatry 2012;72:964-70 «PMID: 22784486»PubMed
- Bruno A, Micò U, Pandolfo G ym. Lamotrigine augmentation of serotonin reuptake inhibitors
in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled
study. J Psychopharmacol 2012;26:1456-62 «PMID: 22351381»PubMed
- Brunoni AR, Moffa AH, Sampaio-Junior B ym. Trial of Electrical Direct-Current Therapy
versus Escitalopram for Depression. N Engl J Med 2017;376:2523-2533 «PMID: 28657871»PubMed
- Chien WT, Tse MK, Chan HY, Cheng HY, Chen L. Is mindfulness-based intervention an
effective treatment for people with obsessive-compulsive disorder? A systematic review
and meta-analysis. J Obsessive Compuls Relat Disord 2022;32; 100712.
- Couto JP, Moreira R. Oral N-acetylcysteine in the treatment of obsessive-compulsive
disorder: A systematic review of the clinical evidence. Prog Neuropsychopharmacol
Biol Psychiatry 2018;86:245-254 «PMID: 29908912»PubMed
- Crockett BA, Churchill E, Davidson JR. A double-blind combination study of clonazepam
with sertraline in obsessive-compulsive disorder. Ann Clin Psychiatry 2004;16:127-32
«PMID: 15517844»PubMed
- Davíðsdóttir SD, Sigurjónsdóttir Ó, Ludvigsdóttir SJ ym. Implementation of the Bergen
4-Day Treatment for Obsessive Compulsive Disorder in Iceland. Clin Neuropsychiatry
2019;16:33-38 «PMID: 34908936»PubMed
- de Boer JN, Vingerhoets C, Hirdes M ym. Efficacy and tolerability of riluzole in psychiatric
disorders: A systematic review and preliminary meta-analysis. Psychiatry Res 2019;278:294-302
«PMID: 31254879»PubMed
- Dèttore D, Pozza A, Andersson G. Efficacy of technology-delivered cognitive behavioural
therapy for OCD versus control conditions, and in comparison with therapist-administered
CBT: meta-analysis of randomized controlled trials. Cogn Behav Ther 2015;44:190-211
«PMID: 25705787»PubMed
- Dold M, Aigner M, Lanzenberger R ym. Antipsychotic Augmentation of Serotonin Reuptake
Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis
of Double-Blind, Randomized, Placebo-Controlled Trials. Int J Neuropsychopharmacol
2015;18: «PMID: 25939614»PubMed
- Donovan MR, Glue P, Kolluri S ym. Comparative efficacy of antidepressants in preventing
relapse in anxiety disorders - a meta-analysis. J Affect Disord 2010;123:9-16 «PMID: 19616306»PubMed
- Dos Santos-Ribeiro S, de Salles Andrade JB, Quintas JN ym. A Systematic Review of
the Utility of Electroconvulsive Therapy in Broadly Defined Obsessive-Compulsive-Related
Disorders. Prim Care Companion CNS Disord 2018;20: «PMID: 30407758»PubMed
- Elliott SJ, Marshall D, Morley K ym. Behavioural and cognitive behavioural therapy
for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder
(ASD). Cochrane Database Syst Rev 2021;9:CD013173 «PMID: 34693989»PubMed
- Emamzadehfard S, Kamaloo A, Paydary K ym. Riluzole in augmentation of fluvoxamine
for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled
study. Psychiatry Clin Neurosci 2016;70:332-41 «PMID: 27106362»PubMed
- Farnia V, Gharehbaghi H, Alikhani M ym. Efficacy and tolerability of adjunctive gabapentin
and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled
trial. J Psychiatr Res 2018;104:137-143 «PMID: 30044966»PubMed
- Farrell LJ, Waters AM, Tiralongo E ym. Efficacy of D-cycloserine augmented brief intensive
cognitive-behavioural therapy for paediatric obsessive-compulsive disorder: A randomised
clinical trial. Depress Anxiety 2022;39:461-473 «PMID: 35084071»PubMed
- Fatori D, de Bragança Pereira CA, Asbahr FR ym. Adaptive treatment strategies for
children and adolescents with Obsessive-Compulsive Disorder: A sequential multiple
assignment randomized trial. J Anxiety Disord 2018;58:42-50 «PMID: 30025255»PubMed
- Ferrando, C., & Selai, C. (2021). A systematic review and meta-analysis on the effectiveness
of exposure and response prevention therapy in the treatment of Obsessive-Compulsive
Disorder. Journal of Obsessive-Compulsive and Related Disorders, 31, 100684. https://doi.org/10.1016/j.jocrd.2021.100684
- Fisher PL, Cherry MG, Stuart T ym. People with obsessive-compulsive disorder often
remain symptomatic following psychological treatment: A clinical significance analysis
of manualised psychological interventions. J Affect Disord 2020;275:94-108 «PMID: 32658831»PubMed
- Fitzsimmons SMDD, van der Werf YD, van Campen AD ym. Repetitive transcranial magnetic
stimulation for obsessive-compulsive disorder: A systematic review and pairwise/network
meta-analysis. J Affect Disord 2022;302:302-312 «PMID: 35041869»PubMed
- Fontenelle LF, Coutinho ES, Lins-Martins NM ym. Electroconvulsive therapy for obsessive-compulsive
disorder: a systematic review. J Clin Psychiatry 2015;76:949-57 «PMID: 25844888»PubMed
- Gadallah AA, Ebada MA, Gadallah A, Ahmed H, Rashad W, Eid KA, Bahbah E, Alkanj S.
Efficacy and safety of N-acetylcysteine as add-on therapy in the treatment of obsessive-compulsive
disorder: A systematic review and meta-analysis. Journal of Obsessive-Compulsive and
Related Disorders 2020;25:100529.
- Geller DA, Biederman J, Stewart SE ym. Which SSRI? A meta-analysis of pharmacotherapy
trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 2003;160:1919-28
«PMID: 14594734»PubMed
- Ghaleiha A, Entezari N, Modabbernia A ym. Memantine add-on in moderate to severe obsessive-compulsive
disorder: randomized double-blind placebo-controlled study. J Psychiatr Res 2013;47:175-80
«PMID: 23063327»PubMed
- Gosmann NP, Costa MA, Jaeger MB ym. Selective serotonin reuptake inhibitors, and serotonin
and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress
disorders: A 3-level network meta-analysis. PLoS Med 2021;18:e1003664 «PMID: 34111122»PubMed
- Gowda SM, Narayanaswamy JC, Hazari N ym. Efficacy of pre-supplementary motor area
transcranial direct current stimulation for treatment resistant obsessive compulsive
disorder: A randomized, double blinded, sham controlled trial. Brain Stimul 2019;12:922-929
«PMID: 30808612»PubMed
- Grant PJ, Joseph LA, Farmer CA ym. 12-week, placebo-controlled trial of add-on riluzole
in the treatment of childhood-onset obsessive-compulsive disorder. Neuropsychopharmacology
2014;39:1453-9 «PMID: 24356715»PubMed
- Haghighi M, Jahangard L, Mohammad-Beigi H ym. In a double-blind, randomized and placebo-controlled
trial, adjuvant memantine improved symptoms in inpatients suffering from refractory
obsessive-compulsive disorders (OCD). Psychopharmacology (Berl) 2013;228:633-40 «PMID: 23525525»PubMed
- Hansen B, Hagen K, Öst LG ym. The Bergen 4-Day OCD Treatment Delivered in a Group
Setting: 12-Month Follow-Up. Front Psychol 2018;9:639 «PMID: 29774005»PubMed
- Havnen A, Hansen B, Öst LG ym. Concentrated ERP Delivered in a Group Setting: A Replication
Study. Behav Cogn Psychother 2017;45:530-536 «PMID: 28287064»PubMed
- Havnen, A., Hansen, B., Öst, L.-G., & Kvale, G. (2014). Concentrated ERP delivered
in a group setting: An effectiveness study. Journal of Obsessive-Compulsive and Related
Disorders, 3(4), 319–324. https://doi.org/10.1016/j.jocrd.2014.08.002
- Heidari M, Zarei M, Hosseini SM ym. Ondansetron or placebo in the augmentation of
fluvoxamine response over 8 weeks in obsessive-compulsive disorder. Int Clin Psychopharmacol
2014;29:344-50 «PMID: 24850229»PubMed
- Heikman P, Katila H, Sarna S ym. Differential response to right unilateral ECT in
depressed patients: impact of comorbidity and severity of illness [ISRCTN39974945].
BMC Psychiatry 2002;2:2 «PMID: 11846888»PubMed
- Hollander E, Kaplan A, Stahl SM. A double-blind, placebo-controlled trial of clonazepam
in obsessive-compulsive disorder. World J Biol Psychiatry 2003;4:30-4 «PMID: 12582975»PubMed
- Hyde J, Carr H, Kelley N ym. Efficacy of neurostimulation across mental disorders:
systematic review and meta-analysis of 208 randomized controlled trials. Mol Psychiatry
2022;27:2709-2719 «PMID: 35365806»PubMed
- Ivarsson T, Skarphedinsson G, Kornør H ym. The place of and evidence for serotonin
reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and
adolescents: Views based on a systematic review and meta-analysis. Psychiatry Res
2015;227:93-103 «PMID: 25769521»PubMed
- Kellner CH, Knapp RG, Petrides G ym. Continuation electroconvulsive therapy vs pharmacotherapy
for relapse prevention in major depression: a multisite study from the Consortium
for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006;63:1337-44
«PMID: 17146008»PubMed
- Khalkhali M, Aram S, Zarrabi H ym. Lamotrigine Augmentation Versus Placebo in Serotonin
Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled
Trial. Iran J Psychiatry 2016;11:104-14 «PMID: 27437007»PubMed
- Komossa K, Depping AM, Meyer M ym. Second-generation antipsychotics for obsessive
compulsive disorder. Cochrane Database Syst Rev 2010;:CD008141 «PMID: 21154394»PubMed
- Kotapati VP, Khan AM, Dar S ym. The Effectiveness of Selective Serotonin Reuptake
Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children:
A Systematic Review and Meta-Analysis. Front Psychiatry 2019;10:523 «PMID: 31447707»PubMed
- Kothari R, Barker C, Pistrang N ym. A randomised controlled trial of guided internet-based
cognitive behavioural therapy for perfectionism: Effects on psychopathology and transdiagnostic
processes. J Behav Ther Exp Psychiatry 2019;64:113-122 «PMID: 30981162»PubMed
- Kvale G, Hansen B, Björgvinsson T ym. Successfully treating 90 patients with obsessive
compulsive disorder in eight days: the Bergen 4-day treatment. BMC Psychiatry 2018;18:323
«PMID: 30286745»PubMed
- Kyrios M, Ahern C, Fassnacht DB ym. Therapist-Assisted Internet-Based Cognitive Behavioral
Therapy Versus Progressive Relaxation in Obsessive-Compulsive Disorder: Randomized
Controlled Trial. J Med Internet Res 2018;20:e242 «PMID: 30089607»PubMed
- Launes G, Hagen K, Sunde T ym. A Randomized Controlled Trial of Concentrated ERP,
Self-Help and Waiting List for Obsessive- Compulsive Disorder: The Bergen 4-Day Treatment.
Front Psychol 2019;10:2500 «PMID: 31803089»PubMed
- Launes G, Hagen K, Öst LG ym. The Bergen 4-Day Treatment (B4DT) for Obsessive-Compulsive
Disorder: Outcomes for Patients Treated After Initial Waiting List or Self-Help Intervention.
Front Psychol 2020;11:982 «PMID: 32528372»PubMed
- Liang K, Li H, Bu X ym. Efficacy and tolerability of repetitive transcranial magnetic
stimulation for the treatment of obsessive-compulsive disorder in adults: a systematic
review and network meta-analysis. Transl Psychiatry 2021;11:332 «PMID: 34050130»PubMed
- Maneeton N, Maneeton B, Karawekpanyawong N ym. Fluoxetine in acute treatment of children
and adolescents with obsessive-compulsive disorder: a systematic review and meta-analysis.
Nord J Psychiatry 2020;74:461-469 «PMID: 32242450»PubMed
- Miegel F, Moritz S, Hottenrott B, Demiralay C, Jelinek L. Metacognitive Training for
Obsessive-Compulsive Disorder: A randomized controlled trial. J Obsessive Compuls
Relat Disord 2021 Jul 1;30:100647.
- Modarresi A, Chaibakhsh S, Koulaeinejad N ym. A systematic review and meta-analysis:
Memantine augmentation in moderate to severe obsessive-compulsive disorder. Psychiatry
Res 2019;282:112602 «PMID: 31630042»PubMed
- Modarresi A, Sayyah M, Razooghi S ym. Memantine Augmentation Improves Symptoms in
Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder: A Randomized
Controlled Trial. Pharmacopsychiatry 2018;51:263-269 «PMID: 29100251»PubMed
- Mowla A, Khajeian AM, Sahraian A ym. Topiramate Augmentation in Resistant OCD: A Double-Blind
Placebo-Controlled Clinical Trial. CNS Spectr 2010;15:613-7 «PMID: 24726048»PubMed
- Mutz J, Edgcumbe DR, Brunoni AR ym. Efficacy and acceptability of non-invasive brain
stimulation for the treatment of adult unipolar and bipolar depression: A systematic
review and meta-analysis of randomised sham-controlled trials. Neurosci Biobehav Rev
2018;92:291-303 «PMID: 29763711»PubMed
- Mutz J, Vipulananthan V, Carter B ym. Comparative efficacy and acceptability of non-surgical
brain stimulation for the acute treatment of major depressive episodes in adults:
systematic review and network meta-analysis. BMJ 2019;364:l1079 «PMID: 30917990»PubMed
- Pagnin D, de Queiroz V, Pini S ym. Efficacy of ECT in depression: a meta-analytic
review. J ECT 2004;20:13-20 «PMID: 15087991»PubMed
- Pearcy CP, Anderson RA, Egan SJ ym. A systematic review and meta-analysis of self-help
therapeutic interventions for obsessive-compulsive disorder: Is therapeutic contact
key to overall improvement? J Behav Ther Exp Psychiatry 2016;51:74-83 «PMID: 26794856»PubMed
- Pellegrini L, Garg K, Enara A ym. Repetitive transcranial magnetic stimulation (r-TMS)
and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder:
A meta-analysis and clinical implications. Compr Psychiatry 2022;118:152339 «PMID: 35917621»PubMed
- Perera MPN, Mallawaarachchi S, Miljevic A ym. Repetitive Transcranial Magnetic Stimulation
for Obsessive-Compulsive Disorder: A Meta-analysis of Randomized, Sham-Controlled
Trials. Biol Psychiatry Cogn Neurosci Neuroimaging 2021;6:947-960 «PMID: 33775927»PubMed
- Petrides G, Fink M, Husain MM ym. ECT remission rates in psychotic versus nonpsychotic
depressed patients: a report from CORE. J ECT 2001;17:244-53 «PMID: 11731725»PubMed
- Philip J, Cherian V. Acceptance and commitment therapy in the treatment of obsessive-compulsive
disorder: A systematic review. J Obsessive Compuls Relat Disord 2021 Jan 1;28:100603.
- Pittenger C, Bloch MH, Wasylink S ym. Riluzole augmentation in treatment-refractory
obsessive-compulsive disorder: a pilot randomized placebo-controlled trial. J Clin
Psychiatry 2015;76:1075-84 «PMID: 26214725»PubMed
- Rapinesi C, Kotzalidis GD, Ferracuti S ym. Brain Stimulation in Obsessive-Compulsive
Disorder (OCD): A Systematic Review. Curr Neuropharmacol 2019;17:787-807 «PMID: 30963971»PubMed
- Rehn S, Eslick GD, Brakoulias V. A Meta-Analysis of the Effectiveness of Different
Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the
Treatment of Obsessive-Compulsive Disorder (OCD). Psychiatr Q 2018;89:645-665 «PMID: 29423665»PubMed
- Reid JE, Laws KR, Drummond L ym. Cognitive behavioural therapy with exposure and response
prevention in the treatment of obsessive-compulsive disorder: A systematic review
and meta-analysis of randomised controlled trials. Compr Psychiatry 2021;106:152223
«PMID: 33618297»PubMed
- Rodriguez CI, Kegeles LS, Levinson A ym. Randomized controlled crossover trial of
ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology
2013;38:2475-83 «PMID: 23783065»PubMed
- Sahraian A, Jahromi LR, Ghanizadeh A ym. Memantine as an Adjuvant Treatment for Obsessive
Compulsive Symptoms in Manic Phase of Bipolar Disorder: A Randomized, Double-Blind,
Placebo-Controlled Clinical Trial. J Clin Psychopharmacol 2017;37:246-249 «PMID: 28099183»PubMed
- Sánchez-Meca J, Rosa-Alcázar AI, Iniesta-Sepúlveda M ym. Differential efficacy of
cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive
disorder: a meta-analysis. J Anxiety Disord 2014;28:31-44 «PMID: 24334214»PubMed
- Sarris J, Byrne G, Castle D ym. N-acetyl cysteine (NAC) augmentation in the treatment
of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized,
placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 2022;117:110550
«PMID: 35304155»PubMed
- Schröder J, Werkle N, Cludius B ym. Unguided Internet-based cognitive-behavioral therapy
for obsessive-compulsive disorder: A randomized controlled trial. Depress Anxiety
2020;37:1208-1220 «PMID: 33169490»PubMed
- Sharma LP, Thamby A, Balachander S ym. Clinical utility of repeated intravenous ketamine
treatment for resistant obsessive-compulsive disorder. Asian J Psychiatr 2020;52:102183
«PMID: 32554207»PubMed
- Silva RMFD, Brunoni AR, Goerigk S ym. Efficacy and safety of transcranial direct current
stimulation as an add-on treatment for obsessive-compulsive disorder: a randomized,
sham-controlled trial. Neuropsychopharmacology 2021;46:1028-1034 «PMID: 33452434»PubMed
- Skapinakis P, Caldwell DM, Hollingworth W ym. Pharmacological and psychotherapeutic
interventions for management of obsessive-compulsive disorder in adults: a systematic
review and network meta-analysis. Lancet Psychiatry 2016;3:730-739 «PMID: 27318812»PubMed
- Skapinakis P, Papatheodorou T, Mavreas V. Antipsychotic augmentation of serotonergic
antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis
of the randomized controlled trials. Eur Neuropsychopharmacol 2007;17:79-93 «PMID: 16904298»PubMed
- Soltani F, Sayyah M, Feizy F ym. A double-blind, placebo-controlled pilot study of
ondansetron for patients with obsessive-compulsive disorder. Hum Psychopharmacol 2010;25:509-13
«PMID: 20737524»PubMed
- Soomro GM, Altman D, Rajagopal S ym. Selective serotonin re-uptake inhibitors (SSRIs)
versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev
2008;2008:CD001765 «PMID: 18253995»PubMed
- Soomro GM. Obsessive compulsive disorder. BMJ Clin Evid 2012;2012: «PMID: 22305974»PubMed
- Storch EA, Goddard AW, Grant JE ym. Double-blind, placebo-controlled, pilot trial
of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive
disorder. J Clin Psychiatry 2013;74:e527-32 «PMID: 23842022»PubMed
- Storch EA, Wilhelm S, Sprich S ym. Efficacy of Augmentation of Cognitive Behavior
Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive
Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2016;73:779-88 «PMID: 27367832»PubMed
- Taiminen T, Jääskeläinen SK. Sarjamagneettistimulaation mahdollisuudet psykiatriassa
ja tulevaisuuden näkymät. Lääkärilehti 51-52/2020 vsk 75.
- Trevizol AP, Shiozawa P, Cook IA ym. Transcranial Magnetic Stimulation for Obsessive-Compulsive
Disorder: An Updated Systematic Review and Meta-analysis. J ECT 2016;32:262-266 «PMID: 27327557»PubMed
- Uhre CF, Uhre VF, Lønfeldt NN ym. Systematic Review and Meta-Analysis: Cognitive-Behavioral
Therapy for Obsessive-Compulsive Disorder in Children and Adolescents. J Am Acad Child
Adolesc Psychiatry 2020;59:64-77 «PMID: 31589909»PubMed
- UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive
disorders: a systematic review and meta-analysis. Lancet 2003;361:799-808 «PMID: 12642045»PubMed
- van Diermen L, van den Ameele S, Kamperman AM ym. Prediction of electroconvulsive
therapy response and remission in major depression: meta-analysis. Br J Psychiatry
2018;212:71-80 «PMID: 29436330»PubMed
- Wergeland GJH, Riise EN, Öst LG. Cognitive behavior therapy for internalizing disorders
in children and adolescents in routine clinical care: A systematic review and meta-analysis.
Clin Psychol Rev 2021;83:101918 «PMID: 33186776»PubMed
- Wootton BM, Karin E, Titov N ym. Self-guided internet-delivered cognitive behavior
therapy (ICBT) for obsessive-compulsive symptoms: A randomized controlled trial. J
Anxiety Disord 2019;66:102111 «PMID: 31301476»PubMed
- Xu J, Hao Q, Qian R ym. Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive
Disorder in Adults: A Systematic Review and Dose-Response Meta-Analysis. Front Psychiatry
2021;12:717999 «PMID: 34630180»PubMed
- Yoosefee S, Amanat M, Salehi M ym. The safety and efficacy of transcranial direct
current stimulation as add-on therapy to fluoxetine in obsessive-compulsive disorder:
a randomized, double-blind, sham-controlled, clinical trial. BMC Psychiatry 2020;20:570
«PMID: 33256659»PubMed
- Zhou DD, Wang W, Wang GM ym. An updated meta-analysis: Short-term therapeutic effects
of repeated transcranial magnetic stimulation in treating obsessive-compulsive disorder.
J Affect Disord 2017;215:187-196 «PMID: 28340445»PubMed
- Zhou DD, Zhou XX, Li Y ym. Augmentation agents to serotonin reuptake inhibitors for
treatment-resistant obsessive-compulsive disorder: A network meta-analysis. Prog Neuropsychopharmacol
Biol Psychiatry 2019;90:277-287 «PMID: 30576763»PubMed
- Zhou DD, Zhou XX, Lv Z ym. Comparative efficacy and tolerability of antipsychotics
as augmentations in adults with treatment-resistant obsessive-compulsive disorder:
A network meta-analysis. J Psychiatr Res 2019;111:51-58 «PMID: 30677645»PubMed
- Zhou S, Fang Y. Efficacy of Non-Invasive Brain Stimulation for Refractory Obsessive-Compulsive
Disorder: A Meta-Analysis of Randomized Controlled Trials. Brain Sci 2022;12: «PMID: 35884749»PubMed
Artikkelin tunnus: nix03232 (050.129)
© 2025 Suomalainen Lääkäriseura Duodecim